Work

Iconography : Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial

Year: 2017

Type: article

Authors: Boni E. Elewski, Martin M. Okun, Kim Papp, Christopher Baker, Jeffrey Crowley, G. Guillet, Murali Sundaram, Yves Poulin, Yihua Gu, Ziqian Geng, David A. Williams, Phoebe Rich

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2783577585

FWCI:

Cites:

Cited by:

Related to: 20